COPS2

COP9 signalosome complex subunit 2 · P61201 · COPS2 on Sugi Atlas →

0 patent compounds predicted against COPS2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to COPS2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Addition of Everolimus to Standard of Care in Carcinoma Gallbladder PHASE2/PHASE3RECRUITING
Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome PHASE3COMPLETED
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
A Prevention Trial in Subjects at High Risk for Breast Cancer PHASE2COMPLETED
Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement Therapy PHASE2COMPLETED
A Study to Test How Well BI 3000202 is Tolerated by People With Type 1 Interferonopathies PHASE1ACTIVE_NOT_RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
MEHMO Natural History and Biomarkers nanRECRUITING
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Chromosome 9 P Minus Syndrome nanRECRUITING
Genetic Analysis of Gray Platelet Syndrome nanCOMPLETED
Implementation of Molecular Diagnostic Pathways nanUNKNOWN
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders nanCOMPLETED
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives nanUNKNOWN
Study of Constitutional Platelet Disease nanUNKNOWN
Phenotype/Genotype Correlations in Neuromuscular Disorders nanCOMPLETED
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Epidemiological and Genetic Studies of Body Mass Index nanCOMPLETED
Diagnostic Research in Patients With Rare Diseases - Solving the Unsolved Rare Diseases nanUNKNOWN
Biochemical and Phenotypical Aspects of Smith-Lemli-Opitz Syndrome and Related Disorders of Cholesterol Metabolism nanRECRUITING
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Use of miRNAs in Growth Hormone Deficiency (GHD) nanUNKNOWN
Immune Cell Response to Stimuli nanRECRUITING
Protein Synthesis in the Brain of Patients With Fragile X Syndrome nanCOMPLETED
Study of The Association of Mutations in The NPHS2 Gene and Nephrotic Syndrome in Children and Adults in Middle East nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a COPS2 binder may also engage these)

ProteinNameSimilarity
P61203 1.000 P61203 →
P61202 1.000 P61202 →
Q6IQT4 1.000 Q6IQT4 →
Q6IR75 1.000 Q6IR75 →
Q99LD4 0.958 Q99LD4 →
P97834 0.958 P97834 →
Q5R532 0.957 Q5R532 →
CDC16 Cell division cycle protein 16 homolog 0.954 landscape →
Q7L5Y9 0.953 Q7L5Y9 →
Q7SXR3 0.952 Q7SXR3 →
Q9UKF6 0.952 Q9UKF6 →
P70168 0.952 P70168 →
Q4R9A8 0.952 Q4R9A8 →
Q5F398 0.951 Q5F398 →
P79101 0.950 P79101 →
P52296 0.949 P52296 →
KPNB1 Importin subunit beta-1 0.949 landscape →
Q5RKJ1 0.948 Q5RKJ1 →
Q4VC33 0.948 Q4VC33 →
Q13888 0.948 Q13888 →
Q6GR10 0.947 Q6GR10 →
Q9JIB4 0.947 Q9JIB4 →
Q6P1K8 0.947 Q6P1K8 →
Q27HV0 0.946 Q27HV0 →
P56558 0.946 P56558 →
Q99LC2 0.946 Q99LC2 →
OGT UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit 0.946 landscape →
Q8CGY8 0.945 Q8CGY8 →
A0JN27 0.944 A0JN27 →
Q9QXK7 0.943 Q9QXK7 →